Free Trial

Anson Funds Management LP Takes Position in Docusign Inc. $DOCU

Docusign logo with Computer and Technology background
Image from MarketBeat Media, LLC.

Key Points

  • Anson Funds Management LP opened a new position in DocuSign, buying 150,000 shares worth about $10.8 million, which makes DOCU roughly 0.9% of Anson’s portfolio and its 19th-largest holding.
  • Analysts have a consensus rating of "Hold" on DOCU with a consensus price target of $78.80, after recent cuts from firms like BTIG (to $70) and Piper Sandler (to $75) despite some "Buy"/"Outperform" calls.
  • Company insiders have sold about 76,493 shares (~$5.24M) in the last three months, while DOCU trades around $47.05 with a 12-month range of $40.16–$94.67 and a market cap near $9.4 billion.
  • Five stocks we like better than Docusign.

Anson Funds Management LP bought a new position in shares of Docusign Inc. (NASDAQ:DOCU - Free Report) during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm bought 150,000 shares of the company's stock, valued at approximately $10,814,000. Docusign comprises about 0.9% of Anson Funds Management LP's portfolio, making the stock its 19th largest holding. Anson Funds Management LP owned 0.07% of Docusign at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently bought and sold shares of DOCU. Vanguard Group Inc. grew its position in Docusign by 1.1% during the 3rd quarter. Vanguard Group Inc. now owns 21,625,551 shares of the company's stock worth $1,558,986,000 after purchasing an additional 225,525 shares during the last quarter. State Street Corp increased its stake in Docusign by 3.0% in the second quarter. State Street Corp now owns 8,074,976 shares of the company's stock valued at $628,960,000 after purchasing an additional 236,494 shares during the period. American Century Companies Inc. raised its holdings in shares of Docusign by 1.6% in the second quarter. American Century Companies Inc. now owns 5,564,318 shares of the company's stock valued at $433,405,000 after buying an additional 86,560 shares during the last quarter. Geode Capital Management LLC raised its holdings in shares of Docusign by 1.5% in the second quarter. Geode Capital Management LLC now owns 3,985,808 shares of the company's stock valued at $309,910,000 after buying an additional 59,941 shares during the last quarter. Finally, Invesco Ltd. boosted its stake in shares of Docusign by 4.5% during the third quarter. Invesco Ltd. now owns 2,690,121 shares of the company's stock worth $193,931,000 after buying an additional 116,047 shares during the period. Hedge funds and other institutional investors own 77.64% of the company's stock.

Analysts Set New Price Targets

Several equities analysts recently issued reports on the company. BTIG Research dropped their price target on Docusign from $88.00 to $70.00 and set a "buy" rating on the stock in a research report on Wednesday, February 18th. Cantor Fitzgerald reaffirmed an "outperform" rating on shares of Docusign in a research report on Wednesday, December 17th. Citigroup reiterated a "market outperform" rating on shares of Docusign in a research note on Monday, March 2nd. Weiss Ratings reissued a "hold (c)" rating on shares of Docusign in a report on Wednesday, January 21st. Finally, Piper Sandler cut their price target on Docusign from $90.00 to $75.00 and set a "neutral" rating for the company in a research note on Friday, December 5th. Five equities research analysts have rated the stock with a Buy rating and sixteen have assigned a Hold rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of "Hold" and a consensus price target of $78.80.

Check Out Our Latest Analysis on DOCU

Docusign Trading Up 1.2%

Shares of DOCU stock opened at $47.05 on Friday. The stock has a 50 day simple moving average of $51.81 and a 200-day simple moving average of $64.94. The company has a market cap of $9.42 billion, a price-to-earnings ratio of 32.90, a price-to-earnings-growth ratio of 2.05 and a beta of 1.03. Docusign Inc. has a 12-month low of $40.16 and a 12-month high of $94.67.

Insiders Place Their Bets

In other news, insider James P. Shaughnessy sold 12,000 shares of the stock in a transaction dated Friday, January 2nd. The shares were sold at an average price of $67.03, for a total value of $804,360.00. Following the completion of the transaction, the insider owned 54,550 shares in the company, valued at $3,656,486.50. This trade represents a 18.03% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, insider Robert Chatwani sold 13,818 shares of the business's stock in a transaction dated Wednesday, December 17th. The stock was sold at an average price of $68.33, for a total transaction of $944,183.94. Following the sale, the insider directly owned 70,197 shares in the company, valued at approximately $4,796,561.01. This represents a 16.45% decrease in their position. The SEC filing for this sale provides additional information. Over the last three months, insiders have sold 76,493 shares of company stock worth $5,235,225. Insiders own 1.01% of the company's stock.

Docusign Company Profile

(Free Report)

DocuSign, Inc NASDAQ: DOCU is a leading provider of electronic signature and digital transaction management solutions. The company's flagship offering, DocuSign eSignature, enables organizations to send, sign and manage legally binding electronic agreements securely in the cloud. Beyond eSignature, DocuSign's Agreement Cloud combines contract lifecycle management, document generation, and workflow automation to streamline agreement processes from initiation through execution and storage.

DocuSign's platform serves a diverse customer base spanning industries such as finance, real estate, healthcare, technology, and government.

Read More

Institutional Ownership by Quarter for Docusign (NASDAQ:DOCU)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Docusign Right Now?

Before you consider Docusign, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Docusign wasn't on the list.

While Docusign currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines